Literature DB >> 21533709

Female reproductive steroids and neuronal excitability.

C Finocchi1, M Ferrari.   

Abstract

Oestrogen and progesterone have specific receptors in the central nervous system and are able to regulate neuronal development and plasticity, neuronal excitability, mitochondrial energy production, and neurotransmitter synthesis, release, and transport. On neuronal excitability, estradiol and progesterone seem to have an opposite effect, with estradiol being excitatory and progesterone and its derivative allopregnanolone being inhibitory. Estradiol augments N-methyl-D-aspartate-mediated glutamate receptor activity, while progesterone enhances gamma-aminobutyric acid-mediated chloride conductance. Sex steroid regulation of the balance of neuroexcitatory and neuroinhibitory activities may have a role in modulating clinical susceptibility to different neurological conditions such as migraine, catamenial epilepsy, premenstrual dysphoric disorder, and premenstrual syndrome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21533709     DOI: 10.1007/s10072-011-0532-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  35 in total

Review 1.  [Gender aspects in anesthesia : modified approach in research and treatment?].

Authors:  M Schopper; P I Bäumler; J Fleckenstein; D Irnich
Journal:  Anaesthesist       Date:  2012-04       Impact factor: 1.041

Review 2.  [Gender differences in acute and chronic pain conditions. Implications for diagnosis and therapy].

Authors:  M Schopper; J Fleckenstein; D Irnich
Journal:  Schmerz       Date:  2013-09       Impact factor: 1.107

Review 3.  The role of reproductive hormones in postpartum depression.

Authors:  Crystal Edler Schiller; Samantha Meltzer-Brody; David R Rubinow
Journal:  CNS Spectr       Date:  2014-09-29       Impact factor: 3.790

Review 4.  The effects of ethinylestradiol and progestins ("the pill") on cognitive function in pre-menopausal women.

Authors:  Andrea Gogos; YeeWen Candace Wu; Amy S Williams; Linda K Byrne
Journal:  Neurochem Res       Date:  2014-09-30       Impact factor: 3.996

5.  Comparative genomic analysis of Mycobacterium neoaurum MN2 and MN4 substrate and product tolerance.

Authors:  Ling-Xia Xu; Hui-Lin Yang; Meng-An Kuang; Zong-Cai Tu; Xiao-Lan Wang
Journal:  3 Biotech       Date:  2017-06-29       Impact factor: 2.406

Review 6.  Allopregnanolone as a mediator of affective switching in reproductive mood disorders.

Authors:  Crystal Edler Schiller; Peter J Schmidt; David R Rubinow
Journal:  Psychopharmacology (Berl)       Date:  2014-05-21       Impact factor: 4.530

7.  Increased glutamate levels in the medial prefrontal cortex in patients with postpartum depression.

Authors:  Alyssa M McEwen; Denee T A Burgess; Christopher C Hanstock; Peter Seres; Panteha Khalili; Stephen C Newman; Glen B Baker; Nicholas D Mitchell; Janisse Khudabux-Der; Peter S Allen; Jean-Michel LeMelledo
Journal:  Neuropsychopharmacology       Date:  2012-07-18       Impact factor: 7.853

Review 8.  Sex-related differences in migraine.

Authors:  Cinzia Finocchi; Laura Strada
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

Review 9.  Neuroendocrine considerations in the treatment of men and women with epilepsy.

Authors:  Cynthia L Harden; Page B Pennell
Journal:  Lancet Neurol       Date:  2013-01       Impact factor: 44.182

Review 10.  A Treatment Approach to Catamenial Epilepsy.

Authors:  Allison Navis; Cynthia Harden
Journal:  Curr Treat Options Neurol       Date:  2016-07       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.